Target intelligence / Profile preview

Cestode mitochondrial oxidative phosphorylation machinery (Cestode OXPHOS)

Target
Cestode OXPHOS
Molecular classification
Enzyme, Enzyme complex, Mitochondrial respiratory chain
01

Overview

The cestode mitochondrial oxidative phosphorylation machinery is a vital metabolic system responsible for ATP production in tapeworms, specifically adapted to the anaerobic or microaerophilic environments of the host's gastrointestinal tract (Tielens, A. G., 1994, Parasitology Today). This machinery differs significantly from mammalian systems by often utilizing a specialized NADH-fumarate reductase pathway, where fumarate acts as the terminal electron acceptor instead of oxygen to maintain redox balance (Kita, K., et al., 2002, Current Medicinal Chemistry). Key components of this system include Complex I (NADH dehydrogenase), Complex II (succinate dehydrogenase/fumarate reductase), and Complex V (ATP synthase). Anthelmintic drugs such as niclosamide target this machinery by uncoupling oxidative phosphorylation, which leads to a lethal depletion of ATP within the parasite (Weinbach, E. C., & Garbus, J., 1969, Nature). Because this metabolic pathway has distinct structural and functional differences from human mitochondrial respiration, it serves as a highly effective target for selective anthelmintic therapy against infections like taeniasis and echinococcosis (Walker, M., et al., 2004, Trends in Parasitology).

Other names
Tapeworm mitochondrial respiratory chainCestode ATP synthesis systemHelminth oxidative phosphorylation pathwayNADH-fumarate reductase systemCestode mitochondrial respiratory chain
02

Mechanism of action

Uncoupling of oxidative phosphorylation and inhibition of anaerobic ATP production via the fumarate reductase pathway (PubChem CID 4477; WHO Model List of Essential Medicines).

03

Biological functions

ATP synthesisEnergy metabolismOxidative phosphorylationAnaerobic respirationFumarate reductionElectron transport
04

Disease associations

InfectionCestodiasisTaeniasisEchinococcosisDiphyllobothriasisCysticercosisHymenolepiasis
05

Safety considerations

Gastrointestinal distress (nausea, vomiting, abdominal pain)Risk of inflammatory response in neurocysticercosis if larvae are killed in the brainLow systemic bioavailability of certain agents (e.g., Niclosamide) limits efficacy against extra-intestinal stagesPotential for drug resistance in endemic areas
06

Interacting drugs

Niclosamide

3 more in the full profile.

07

Biomarkers

Fecal egg countProglottid identification in stoolSerum antibody titers (ELISA/EITB)Cyst identification via MRI or CT imaging

Beyond the preview

Go deeper on Cestode mitochondrial oxidative phosphorylation machinery (Cestode OXPHOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cestode mitochondrial oxidative phosphorylation machinery (Cestode OXPHOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call